PMD - Psychemedics Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
19.17
-0.20 (-1.03%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close19.37
Open19.34
Bid0.00 x 800
Ask0.00 x 900
Day's Range19.17 - 19.46
52 Week Range15.99 - 22.88
Volume6,660
Avg. Volume21,660
Market Cap105.574M
Beta0.52
PE Ratio (TTM)17.43
EPS (TTM)1.10
Earnings DateJul 31, 2018 - Aug 6, 2018
Forward Dividend & Yield0.72 (3.74%)
Ex-Dividend Date2018-08-06
1y Target Est32.00
Trade prices are not sourced from all markets
  • Is Psychemedics Corporation (NASDAQ:PMD) Attractive At Its Current PE Ratio?
    Simply Wall St.9 days ago

    Is Psychemedics Corporation (NASDAQ:PMD) Attractive At Its Current PE Ratio?

    This article is intended for those of you who are at the beginning of your investing journey and want to begin learning about how to value company based on itsRead More...

  • Associated Press2 months ago

    Psychemedics: 2Q Earnings Snapshot

    On a per-share basis, the Acton, Massachusetts-based company said it had profit of 21 cents. The drug testing company posted revenue of $10.8 million in the period. Psychemedics shares have fallen nearly ...

  • GlobeNewswire2 months ago

    Psychemedics Announces 2Q Record Revenues

    ACTON, Mass., July 24, 2018-- Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2018. The Company also announced a quarterly dividend of $0.18 per ...

  • Did Psychemedics Corporation (NASDAQ:PMD) Create Value For Shareholders?
    Simply Wall St.3 months ago

    Did Psychemedics Corporation (NASDAQ:PMD) Create Value For Shareholders?

    The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want a simplistic look at the returnRead More...

  • ACCESSWIRE5 months ago

    EX-Dividend Schedule: Psychemedics Boosted its Dividend by 20%; Will Trade Ex-Dividend on May 7, 2018

    LONDON, UK / ACCESSWIRE / May 4, 2018 / Active-Investors has a free review on Psychemedics Corp. (NASDAQ: PMD) following the Company's announcement that it will begin trading ex-dividend on May 07, 2018. Active-Investors has initiated due-diligence on this dividend stock. If your portfolio includes dividend stocks, you have come to the right place for timely information.

  • Associated Press5 months ago

    Psychemedics: 1Q Earnings Snapshot

    The Acton, Massachusetts-based company said it had profit of 23 cents per share. The drug testing company posted revenue of $10.9 million in the period. Psychemedics shares have climbed slightly more than ...

  • ACCESSWIRE6 months ago

    Free Research Report as IQVIA’s Quarterly Revenues Grew 10.7%; Turned Profitable Y-O-Y

    Stock Monitor: Psychemedics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 23, 2018 / Active-Investors.com has just released a free earnings report on IQVIA Holdings Inc. (NYSE: IQV ) ("IQVIA"). ...

  • Only 3 Days Left To Cash In On Psychemedics Corporation (NASDAQ:PMD) Dividend, Is It Worth Buying?
    Simply Wall St.6 months ago

    Only 3 Days Left To Cash In On Psychemedics Corporation (NASDAQ:PMD) Dividend, Is It Worth Buying?

    Attention dividend hunters! Psychemedics Corporation (NASDAQ:PMD) will be distributing its dividend of $0.15 per share on the 29 March 2018, and will start trading ex-dividend in 3 days time onRead More...

  • March Undervalued Utilities Stock Opportunities
    Simply Wall St.6 months ago

    March Undervalued Utilities Stock Opportunities

    Psychemedics and Owens & Minor are utilities stocks on my list that are potentially undervalued. This means their current share prices are trading well-below what the companies are actually worth.Read More...

  • Associated Press6 months ago

    Psychemedics posts 4Q profit

    On a per-share basis, the Acton, Massachusetts-based company said it had net income of 42 cents. Earnings, adjusted for pretax gains, were 22 cents per share. The drug testing company posted revenue of ...

  • 6 Cheap Stocks With a High Dividend Yield
    GuruFocus.com9 months ago

    6 Cheap Stocks With a High Dividend Yield

    Companies with negative stock momentum

  • Capital Cube10 months ago

    ETFs with exposure to Psychemedics Corp. : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
    Simply Wall St.11 months ago

    Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?

    Investors who want to cash in on Psychemedics Corporation’s (NASDAQ:PMD) upcoming dividend of $0.15 per share have only 3 days left to buy the shares before its ex-dividend date, 03Read More...

  • Capital Cube11 months ago

    ETFs with exposure to Psychemedics Corp. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
    Capital Cube11 months ago

    Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Psychemedics Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Enzo Biochem, Inc., Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings (NEO-US, ENZ-US, DGX-US and LH-US) that have also reported for this period. ... Read more (Read more...)

  • PR Newswire11 months ago

    Psychemedics Corporation Announces Q3 Earnings

    DECLARES 85TH CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass. , Oct. 24, 2017 /PRNewswire/ -- Psychemedics Corporation (NASDAQ: PMD) today announced third quarter financial results for the period ended September ...

  • Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
    Simply Wall St.last year

    Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?

    Psychemedics Corporation (NASDAQ:PMD) trades with a trailing P/E of 13.6x, which is lower than the industry average of 21.5x. While PMD might seem like an attractive stock to buy, itRead More...

  • PR Newswirelast year

    Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

    ACTON, Mass., Sept. 26, 2017 /PRNewswire/ -- Psychemedics Corporation (PMD), hair testing pioneer and global leader for over thirty years, announced the launch of its FDA-Cleared Benzodiazepines hair test.  The test detects numerous Benzodiazepines, including Xanax®, Valium®, and Ativan®, and is available as a stand-alone test or as an option on Psychemedics' standard drug panels. The abuse of prescription Benzodiazepines has grown at an alarming rate in the United States, contributing to thousands of emergency room visits and overdose deaths each year. It is important to note that Benzodiazepines can prove deadly when combined with other depressants, including alcohol.  This significantly increases the danger of Benzodiazepine abuse.

  • Capital Cubelast year

    ETFs with exposure to Psychemedics Corp. : September 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Psychemedics Corp. Here are 5 ETFs with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)